FAQ Directory: HEDIS

Filter Results
  • Save
    Save your favorite pages and receive notifications whenever they’re updated. You will be prompted to log in to your NCQA account.
  • Email
    Share this page with a friend or colleague by Email. We do not share your information with third parties.
  • Print this page.

11.16.2026 Vaginal Specimen Source for the CCS-E measure Does an HPV test that has a vaginal sample source meet criteria for the numerator?

Yes. If the HPV sample is obtained vaginally and can be mapped to an appropriate code in the value sets, it may be used to meet criteria.

**This FAQ applies to HEDIS Volume 2 MY 2026 & MY 2027.  

HEDIS MY 2027

11.16.2026 Codes for Person-Centered Outcome Goal Domains Why are codes for goal domains not included in the new Person-Centered Outcome Goal measures?

When the measures were released, standardized codes were not available. Therefore, the measure looks for any “not null” value which allows organizations to use their own internal proprietary codes for MY 2027 reporting.

Standardized codes for the recommended goal domains became available in the September 2026 release of SNOMED CT United States Edition. We anticipate the codes will be added to the measures for optional use in HEDIS MY 2028.

HEDIS MY 2027

11.16.2026 Standardized Clinical Questions for Tobacco Use Screenings Does tobacco use screening require the use of a standardized question?

No, while two standardized tobacco use screening questions exist and are included in the Tobacco Use Screening value set, use of a standardized question is not required. A direct reference code (LOINC code 72166-2) and a code in the Tobacco Use Screening Value Set (LOINC code 39240-7) can be used to document tobacco use status without using a standardized screening question. Organizations should use the option that most accurately describes the person’s tobacco use status.

HEDIS MY 2027

10.15.2026 Cervical Cancer Screening (CCS-E) Vaginal HPV Self-Swab Identification How can organizations identify vaginal self-swab HPV samples for the CCS-E measure?

The CCS-E measure allows at-home, self-collected HPV vaginal samples that are sent to a laboratory or provider's office for analysis (see General Guideline: Self-Collected Samples). Organizations can identify qualifying screenings through multiple approved data sources, including claims, laboratory data, electronic clinical data and medical records. The absence of a specific code does not exclude identification of a qualifying screening if the organization can demonstrate numerator compliance using an approved data source that meets the requirements of the measure.

When using supplemental data (e.g., laboratory data, electronic clinical data or medical record documentation) to assess the numerator (i.e., the provider did not bill one of the codes in the measure), the documentation must meet the requirements outlined in General Guideline: Supplemental Data. NCQA does not approve code mapping, and the auditor will determine whether the data meet the intent of the measure.

If a laboratory bills for the test using any of the CPT codes in the High Risk HPV Lab Test Value Set then this meets numerator criteria. The CPT codes are not specific to sample type (vaginal versus cervical) therefore billing is based on the specific assay and types being detected by the laboratory.

 

**This FAQ applies to HEDIS Volume 2 MY 2026 & MY 2027. 

HEDIS MY 2027

10.15.2026 HEDIS MY 2027 Measure Retirements What measures were approved for retirement in HEDIS MY 2027?

The measures approved for HEDIS MY 2027 retirement were:

  • Documented Assessment After Mammogram (DBM-E)
  • Oral Evaluation, Dental Services (OED)
  • Topical Fluoride for Children (TFC)
  • Diagnosed Mental Health Disorders (DMH)
  • Diagnosed Substance Use Disorders (DSU)
  • Diabetes Monitoring for People With Diabetes and Schizophrenia (SMD)
  • Cardiovascular Monitoring for People With Cardiovascular Disease and Schizophrenia (SMC)
  • Use of Opioids at High Dosage (HDO)
  • Risk of Continued Opioid Use (COU)
  • Language Description of Membership (LDM)

HEDIS MY 2027

10.15.2026 HEDIS MY 2027 Measure Retirements What is the final NCQA-supported version of the retired MY 2027 measures?

The final NCQA-supported version of these retired measures are the HEDIS MY 2026 Volume 2 Technical Update version of the measure specifications. Any subsequent change to a measure specification is an independently modified version and is not maintained, reviewed or endorsed by NCQA. 

HEDIS MY 2027

10.15.2026 HEDIS MY 2027 Measure Retirements When will these measures be removed from HEDIS MY 2027 Volume 2?

The retired measures will be removed in the HEDIS MY 2027 Technical Specification Update release on March 31, 2027.

HEDIS MY 2027

10.15.2026 HEDIS MY 2027 Measure Retirements Will NCQA maintain the measures post-retirement?

NCQA will not maintain the measures post-retirement. Organizations that choose to use a retired measure are responsible for determining whether and how to use, adapt, update or interpret it. NCQA assumes no responsibility for the continued availability, accuracy, maintenance or licensing of retired measure value sets.

HEDIS MY 2027

10.15.2026 Cervical Cancer Screening (CCS-E) LOINC Codes for Vaginal HPV Self-Swab Are there LOINC codes available to capture Vaginal self-swab HPV samples for the CCS-E measure?

No, because new LOINC codes were released after publication of MY 2026, organizations can use supplemental data to meet the numerator requirements. The documentation must meet the requirements outlined in General Guideline: Supplemental Data. NCQA does not approve code mapping, and the auditor will determine whether the data meet the intent of the measure.

New codes for self-collected specimens were included in LOINC’s recent release and additional pre-release codes are currently published on the LOINC website (and will be included in the next LOINC release).  NCQA will review and include appropriate codes in the MY 2027 Technical Update release scheduled for March 31, 2027.

**This FAQ applies to HEDIS Volume 2 MY 2026 & MY 2027.  

HEDIS MY 2027

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: What to Expect What changes will I notice in the updated specification structure?

Organizations may notice:
•    More detailed descriptions of data sources.
•    Terminology aligned with the FHIR® data model.
•    Timing and status language that aligns with FHIR®-based digital measures.
•    A connection between narrative specifications and digital measure specifications.

The updated structure is intended to help organizations understand how existing narrative specifications align with their digital equivalents. It is not intended to change reporting requirements for current HEDIS submissions.

HEDIS MY 2028

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: Any Impacts to Rates or Trending Will the updated specification structure affect performance rates, measure results or historical trending?

No. Because the updates do not change measure intent, calculation logic, reporting requirements or audit expectations, NCQA does not anticipate an impact on performance results or historical trending. Organizations should continue reporting using the same processes they use today.

HEDIS MY 2028

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: Any Requirements for adoption of Digital HEDIS or FHIR-based reporting Do these updates mean that organizations must move to Digital HEDIS or FHIR-based reporting?

No. Traditional HEDIS reporting remains supported. The updated structure introduces terminology and structure that align with FHIR-based digital measures, but it does not require organizations to adopt Digital HEDIS or change their current reporting approach. Organizations may continue using their existing reporting methods while gaining visibility into how those specifications align with future digital quality measurement models.

HEDIS MY 2028